Clinical Trial Update: A Study to Investigate the Safety, Efficacy and Pharmacokinetic Profile of Multiple Doses of QL-007 in Chronic Hepatitis B Patients [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating safety, efficacy and pharmacokinetics of multiple doses of the investigational drug QL-007 in patients with chronic hepatitis …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• QL-007 (QL-007)

Snippet

Sponsor: Qilu Pharmaceutical Co., Ltd. | Conditions: Chronic Hepatitis b | Phase 1 | Status: UNKNOWN